Literature DB >> 27351339

Regional distributions of brain glutamate and glutamine in normal subjects.

Mohammed Z Goryawala1, Sulaiman Sheriff1, Andrew A Maudsley1.   

Abstract

Glutamate (Glu) and glutamine (Gln) play an important role in neuronal regulation and are of value as MRS-observable diagnostic biomarkers. In this study the relative concentrations of these metabolites have been measured in multiple regions in the normal brain using a short-TE whole-brain MRSI measurement at 3 T combined with a modified data analysis approach that used spatial averaging to obtain high-SNR spectra from atlas-registered anatomic regions or interest. By spectral fitting of high-SNR spectra this approach yielded reliable measurements across a wide volume of the brain. Spectral averaging also demonstrated increased SNR and improved fitting accuracy for the sum of Glu and Gln (Glx) compared with individual voxel fitting. Results in 26 healthy controls showed relatively constant Glu/Cr and Gln/Cr throughout the cerebrum, although with increased values in the anterior cingulum and paracentral lobule, and increased Gln/Cr in the superior motor area. The deep gray-matter regions of thalamus, putamen, and pallidum show lower Glu/Cr compared with cortical white-matter regions. Lobar measurements demonstrated reduced Glu/Cr and Gln/Cr in the cerebellum as compared with the cerebrum, where white-matter regions show significantly lower Glu/Cr and Gln/Cr as compared with gray-matter regions across multiple brain lobes. Regression analysis showed no significant effect of gender on Glu/Cr or Gln/Cr measurement; however, Glx/Cr ratio was found to be significantly negatively correlated with age in some lobar brain regions. In summary, this methodology provides the spectral quality necessary for reliable separation of Glu and Gln at 3 T from a single MRSI acquisition enabling generation of regional distributions of metabolites over a large volume of the brain, including cortical regions.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRSI; aging; glutamate; glutamine; spectroscopy

Mesh:

Substances:

Year:  2016        PMID: 27351339      PMCID: PMC4962701          DOI: 10.1002/nbm.3575

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  51 in total

1.  Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy.

Authors:  Andreas Ebel; Andrew A Maudsley
Journal:  Magn Reson Imaging       Date:  2003-02       Impact factor: 2.546

2.  ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra.

Authors:  Rolf F Schulte; Peter Boesiger
Journal:  NMR Biomed       Date:  2006-04       Impact factor: 4.044

Review 3.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

4.  Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy.

Authors:  S Andrea Wijtenburg; Jack Knight-Scott
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

5.  Improving 1H MRSI measurement of cerebral lactate for clinical applications.

Authors:  Neva M Corrigan; Todd L Richards; Seth D Friedman; Helen Petropoulos; Stephen R Dager
Journal:  Psychiatry Res       Date:  2010-03-16       Impact factor: 3.222

6.  Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T.

Authors:  Lana G Kaiser; Norbert Schuff; Nathan Cashdollar; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

Review 7.  A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging.

Authors:  Kristin K Haga; Yuet Peng Khor; Andrew Farrall; Joanna M Wardlaw
Journal:  Neurobiol Aging       Date:  2007-08-23       Impact factor: 4.673

8.  Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil.

Authors:  Shang-Yueh Tsai; Ricardo Otazo; Stefan Posse; Yi-Ru Lin; Hsiao-Wen Chung; Lawrence L Wald; Graham C Wiggins; Fa-Hsuan Lin
Journal:  Magn Reson Med       Date:  2008-05       Impact factor: 4.668

9.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

10.  Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T.

Authors:  Jeff Snyder; Alan Wilman
Journal:  J Magn Reson       Date:  2009-12-04       Impact factor: 2.229

View more
  24 in total

1.  Longitudinal MR Spectroscopy Shows Altered Metabolism in Traumatic Brain Injury.

Authors:  Andrew A Maudsley; Varan Govind; Gaurav Saigal; Stuart G Gold; Leo Harris; Sulaiman Sheriff
Journal:  J Neuroimaging       Date:  2017-07-23       Impact factor: 2.486

2.  Spectral decomposition for resolving partial volume effects in MRSI.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Radka Stoyanova; Andrew A Maudsley
Journal:  Magn Reson Med       Date:  2017-11-11       Impact factor: 4.668

3.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

4.  Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.

Authors:  Yue Zhang; Edward Taub; Nouha Salibi; Gitendra Uswatte; Andrew A Maudsley; Sulaiman Sheriff; Brent Womble; Victor W Mark; David C Knight
Journal:  NMR Biomed       Date:  2018-02-13       Impact factor: 4.044

5.  Cerebral Metabolites on the Descending Limb of Acute Alcohol: A Preliminary 1H MRS Study.

Authors:  Mollie A Monnig; Adam J Woods; Edward Walsh; Christina M Martone; Jonah Blumenthal; Peter M Monti; Ronald A Cohen
Journal:  Alcohol Alcohol       Date:  2019-01-09       Impact factor: 2.826

6.  Regional Metabolite Concentrations in Aging Human Brain: Comparison of Short-TE Whole Brain MR Spectroscopic Imaging and Single Voxel Spectroscopy at 3T.

Authors:  Helen Maghsudi; Birte Schmitz; Andrew A Maudsley; Sulaiman Sheriff; Paul Bronzlik; Martin Schütze; Heinrich Lanfermann; Xiaoqi Ding
Journal:  Clin Neuroradiol       Date:  2019-01-18       Impact factor: 3.649

7.  Effects of apodization smoothing and denoising on spectral fitting.

Authors:  Mohammed Goryawala; Molly Sullivan; Andrew A Maudsley
Journal:  Magn Reson Imaging       Date:  2020-04-22       Impact factor: 2.546

8.  Cardiovascular risks impact human brain N-acetylaspartate in regionally specific patterns.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Hongji Chen; Andrew A Maudsley; Sulaiman Sheriff; Shuo Chen; Anya Savransky; Wyatt Marshall; Meghann C Ryan; Heather A Bruce; Alan R Shuldiner; Braxton D Mitchell; Peter Kochunov; L Elliot Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

9.  Advanced Hadamard-encoded editing of seven low-concentration brain metabolites: Principles of HERCULES.

Authors:  Georg Oeltzschner; Muhammad G Saleh; Daniel Rimbault; Mark Mikkelsen; Kimberly L Chan; Nicolaas A J Puts; Richard A E Edden
Journal:  Neuroimage       Date:  2018-10-06       Impact factor: 6.556

10.  The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.

Authors:  Mohammed Goryawala; Efrat Saraf-Lavi; Natalia Nagornaya; Deborah Heros; Ricardo Komotar; Andrew A Maudsley
Journal:  J Neuroimaging       Date:  2019-12-23       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.